Concord Wealth Partners Sells 90 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Concord Wealth Partners trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,092 shares of the medical equipment provider’s stock after selling 90 shares during the period. Concord Wealth Partners’ holdings in Intuitive Surgical were worth $570,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of ISRG. State Street Corp boosted its stake in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares in the last quarter. FMR LLC boosted its position in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Geode Capital Management LLC increased its stake in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after acquiring an additional 143,440 shares during the period. Fisher Asset Management LLC raised its position in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after purchasing an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. lifted its stake in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after purchasing an additional 24,183 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $571.88 on Friday. The firm’s fifty day moving average is $550.40 and its two-hundred day moving average is $508.94. The firm has a market cap of $203.69 billion, a PE ratio of 89.22, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Bernstein Bank upped their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock worth $15,357,560 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.